Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diarrhea-predominant Irritable Bowel Syndrome”

116 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 116 results

Testing effectiveness (Phase 2)Study completedNCT03931785
What this trial is testing

MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome With Diarrhea (IBS-D)
Ironwood Pharmaceuticals, Inc. 515
Testing effectiveness (Phase 2)Study completedNCT00461526
What this trial is testing

Diarrhea Predominant Irritable Bowel Syndrome in Females

Who this might be right for
Irritable Bowel Syndrome
Bausch Health Americas, Inc. 240
Testing effectiveness (Phase 2)Study completedNCT02757105
What this trial is testing

Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Irritable Bowel Syndrome With Diarrhea
RedHill Biopharma Limited 127
Post-approval studies (Phase 4)Study completedNCT01886781
What this trial is testing

Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
University of Stellenbosch 81
Testing effectiveness (Phase 2)Study completedNCT01130272
What this trial is testing

Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea

Who this might be right for
Irritable Bowel Syndrome
Furiex Pharmaceuticals, Inc 807
Post-approval studies (Phase 4)Study completedNCT03557788
What this trial is testing

Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome With Diarrhea
National University Hospital, Singapore 33
Early research (Phase 1)Study completedNCT05816681
What this trial is testing

Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.

Who this might be right for
Diarrhea
Daewoong Pharmaceutical Co. LTD. 60
Post-approval studies (Phase 4)Study completedNCT02111603
What this trial is testing

Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile Acids

Who this might be right for
Diarrhea Predominant Irritable Bowel Syndrome
Mayo Clinic 13
Large-scale testing (Phase 3)Study completedNCT01736423
What this trial is testing

A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome

Who this might be right for
Diarrhea-predominant Irritable Bowel Syndrome
Astellas Pharma Inc 151
Testing effectiveness (Phase 2)Study completedNCT01327300
What this trial is testing

Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS)

Who this might be right for
Irritable Bowel Syndrome
University of Florida 7
Early research (Phase 1)Looking for participantsNCT06960369
What this trial is testing

Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Irritable Bowel SyndromeIrritable Bowel Syndrome With Diarrhea (IBS-D)Repetitive Transcranial Magnetic Stimulation (rTMS)+3 more
The First Affiliated Hospital of Soochow University
Testing effectiveness (Phase 2)Study completedNCT01855711
What this trial is testing

Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS)

Who this might be right for
Irritable Colon
GlaxoSmithKline 32
Large-scale testing (Phase 3)Study completedNCT01100684
What this trial is testing

Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)

Who this might be right for
Diarrhea Predominant Irritable Bowel Syndrome
Tioga Pharmaceuticals 611
Testing effectiveness (Phase 2)Study completedNCT03977155
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Diarrhea-predominant Irritable Bowel Syndrome
Boston Pharmaceuticals 133
Large-scale testing (Phase 3)WithdrawnNCT02545413
What this trial is testing

Study to Determine Efficacy of Probiotics in Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
Next Gen Pharma India Pvt. Ltd.
Not applicableStudy completedNCT00616200
What this trial is testing

Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS)

Who this might be right for
Diarrhea Predominant Irritable Bowel Syndrome
University of North Carolina, Chapel Hill 17
Post-approval studies (Phase 4)Study completedNCT00370032
What this trial is testing

Study to Assess the Effect Of Alosetron On Mucosal Blood Flow

Who this might be right for
Irritable Colon
GlaxoSmithKline 49
Not applicableStudy completedNCT02728063
What this trial is testing

Lactibiane Tolérance® in Individuals Suffering From Irritable Bowel Syndrome With Diarrheal Predominance

Who this might be right for
Diarrhea Predominant Irritable Bowel Syndrome
PiLeJe 30
Large-scale testing (Phase 3)Study completedNCT00189696
What this trial is testing

Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)

Who this might be right for
Irritable Bowel Syndrome
Astellas Pharma Inc
Post-approval studies (Phase 4)Not Yet RecruitingNCT07061184
What this trial is testing

Fengliao Changweikang for Diarrhea-predominant Irritable Bowel Syndrome: N-of-1 Trial

Who this might be right for
Irritable Bowel Syndrome - DiarrhoeaTraditional Chinese Medicine (TCM)N of 1 Study Design+1 more
Peking Union Medical College Hospital 50
Load More Results
400